GB0625965D0 - Medicaments for wound healing - Google Patents

Medicaments for wound healing

Info

Publication number
GB0625965D0
GB0625965D0 GBGB0625965.9A GB0625965A GB0625965D0 GB 0625965 D0 GB0625965 D0 GB 0625965D0 GB 0625965 A GB0625965 A GB 0625965A GB 0625965 D0 GB0625965 D0 GB 0625965D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
wound healing
healing
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0625965.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Priority to GBGB0625965.9A priority Critical patent/GB0625965D0/en
Publication of GB0625965D0 publication Critical patent/GB0625965D0/en
Priority to PCT/GB2007/004958 priority patent/WO2008078099A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0625965.9A 2006-12-23 2006-12-23 Medicaments for wound healing Ceased GB0625965D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0625965.9A GB0625965D0 (en) 2006-12-23 2006-12-23 Medicaments for wound healing
PCT/GB2007/004958 WO2008078099A1 (en) 2006-12-23 2007-12-21 Lxr- antagonists for the prevention, reduction or inhibition of scarring

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0625965.9A GB0625965D0 (en) 2006-12-23 2006-12-23 Medicaments for wound healing

Publications (1)

Publication Number Publication Date
GB0625965D0 true GB0625965D0 (en) 2007-02-07

Family

ID=37759099

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0625965.9A Ceased GB0625965D0 (en) 2006-12-23 2006-12-23 Medicaments for wound healing

Country Status (2)

Country Link
GB (1) GB0625965D0 (en)
WO (1) WO2008078099A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006047022A1 (en) 2004-10-25 2006-05-04 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
US8399441B2 (en) 2004-10-25 2013-03-19 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
US8725477B2 (en) 2008-04-10 2014-05-13 Schlumberger Technology Corporation Method to generate numerical pseudocores using borehole images, digital rock samples, and multi-point statistics
RU2440591C2 (en) 2008-04-10 2012-01-20 Шлюмбергер Текнолоджи Б.В. Method of obtaining characteristics of geological formation intersected by well
US8311788B2 (en) 2009-07-01 2012-11-13 Schlumberger Technology Corporation Method to quantify discrete pore shapes, volumes, and surface areas using confocal profilometry
US9034859B2 (en) 2011-04-06 2015-05-19 Virginia Commonwealth University Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
US9428753B2 (en) 2013-03-15 2016-08-30 The Governing Council Of The University Of Toronto Use of LXR antagonists for treatment of side effects of elevated glucocorticoid levels
US9416149B2 (en) * 2013-04-25 2016-08-16 University Of Iowa Research Foundation Methods to modulate Rac1 import and to treat pulmonary fibrosis
CN105358190A (en) * 2013-05-01 2016-02-24 法纳克斯株式会社 Adhesion preventing agent
MX2016008459A (en) 2013-12-24 2016-10-14 Univ Virginia Commonwealth Uses of oxygenated cholesterol sulfates (ocs).
PT3494125T (en) 2016-08-02 2022-07-07 Durect Corp Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060052457A1 (en) * 2002-03-11 2006-03-09 Peter Zahradka Use of ppar alpha agonists for the treatment of vascular and renal diseases
US20040224006A1 (en) * 2003-04-21 2004-11-11 Samn Raffaniello Ancrod irradiated, impregnated or coated sutures and other first aid or wound management bandaging materials for minimizing scarring and/or preventing excessive scar formation

Also Published As

Publication number Publication date
WO2008078099A1 (en) 2008-07-03

Similar Documents

Publication Publication Date Title
GB0625963D0 (en) Medicaments and methods for wound healing
EP1981457A4 (en) Surgical wound dressing
PL2021047T3 (en) Device for wound therapy
IL192565A0 (en) Medicament for topical use
GB0625965D0 (en) Medicaments for wound healing
IL197316A0 (en) Buprenophine-wafer for drug substitution therapy
GB0608437D0 (en) Wound dressings
ZA200808336B (en) Multi-layer wound dressings
GB0610680D0 (en) Therapeutic compounds
HK1123545A1 (en) Therapeutic compounds
IL187753A0 (en) Wound healing
GB0603041D0 (en) Therapeutic compounds
EP1965818A4 (en) Methods for wound healing
HK1203925A1 (en) Therapeutic compounds
GB0606663D0 (en) Therapeutic compounds
GB0721332D0 (en) Medicaments
GB0615809D0 (en) Therapeutic compounds
EP2001489A4 (en) Pharmaceutical compositions for promoting wound healing
GB0612971D0 (en) Therapeutic compounds
EP2120967A4 (en) Method for promoting wound healing
GB0625783D0 (en) Medicament
GB0625966D0 (en) Medicaments and methods for promoting wound contraction
GB0625349D0 (en) Therapeutic compounds
GB0619375D0 (en) Wound healing compositions
EP2079704A4 (en) Therapeutic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)